ECONOMIC BRIEFS

Slovak SAX index hits yet another low

The Slovak SAX index hit yet another all time low on October 21, falling 2.34 points or 2.48% to 91.93 in quiet trading. The drop was caused by decreases in the prices of drugs-maker Slovakofarma and refinery Slovnaft by 6.3 and 4.4% respectively. "General lethargy persists," J&T Securities Marian Herman said after the close, adding that the markets were waiting for signals from a new government, signs of crown stability or global investment climate changes. "Foreign investors seem to be waiting to hear something positive about the market," he added. Overall volume, including direct trades registered at the bourse, was 11,056 shares up from 9,533 shares traded on October 20. Turnover was 86.62 million crowns ($2.39 million) up from 5.00 million crowns.

Get daily Slovak news directly to your inbox

Top stories

From COVID-19 miracle to apparent resignation to death and dying

The natural reflex of all failed politicians – and their uncritical fan clubs – is to point to cultural or geographical differences between “us” and “them”.

The COVID-19 ward in the University Hospital Martin

Developed at home, the production of Slovakia's COVID-19 vaccine will move abroad

Neuroimmunologist Norbert Žilka oversees the development of the ACvac1 vaccine at Axon Neuroscience.

Norbert Žilka is the director of the Institute of Neuroimmunology of the Slovak Academy of Sciences (SAV) and also the scientific director of Axon Neuroscience.